"Global Rabies Prophylaxis Market – Industry Trends and Forecast to 2029
Global Rabies Prophylaxis Market, By Type (Furious Rabies, Paralytic Rabies, Others), Treatment (Rabies Immunoglobulin, Vaccines, Antiviral drugs, Others), Route of Administration (Oral, Parenteral, Others), End-Users (Hospitals, Specialty Clinics, Homecare, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others) – Industry Trends and Forecast to 2029
Data Bridge Market Research analyses that the rabies prophylaxis market was valued at USD 910.95 million in 2021 and is expected to reach USD 1226.01 million by 2029, registering a CAGR of 4.20% during the forecast period of 2022 to 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Access Full 350 Pages PDF Report @
https://www.databridgemarketresearch.com/reports/global-rabies-prophylaxis-market
The rabies virus, which belongs to the family Rhabodoviridae, causes rabies, a serious disease. Rabies is generally a disease that affects animals, but it can also affect humans through bites from dogs, raccoons, cats, foxes, bats, and other mammals. The rabies virus attacks the central nervous system, resulting in brain damage and death. Early rabies symptoms are similar to those of other diseases; however, as the disease progresses, particular symptoms emerge, such as hallucination, sleeplessness, anxiety, paralysis, hyper salivation, hydrophobia, and so on. Rabies can be prevented using an inactivated rabies virus vaccination. The vaccine is only given to patients who are considered to be at high risk. It's also administered to people after they've been exposed to the disease to keep them from getting rabies.
**Segments**
- **Type**: The rabies prophylaxis market can be segmented into biological products and non-biological products. Biological products include vaccines, such as purified chick embryo cell vaccine (PCECV), rabies vaccine adsorbed (RVA), and others. Non-biological products consist of immunoglobulins.
- **Distribution Channel**: The market can also be segregated based on the distribution channel into hospitals, retail pharmacies, e-commerce, and others. Hospitals are the primary sources for rabies prophylaxis due to the administration of vaccines and immunoglobulins by healthcare professionals. Retail pharmacies and e-commerce platforms are gaining traction due to the convenience and accessibility they offer to consumers.
- **End-User**: End-users in the rabies prophylaxis market include humans and animals. Human prophylaxis involves the administration of vaccines and immunoglobulins post-exposure to the rabies virus. Animal prophylaxis includes vaccination programs to control rabies transmission in domestic and wild animals.
**Market Players**
- **Sanofi**: One of the leading players in the rabies prophylaxis market, Sanofi offers a range of rabies vaccines for both pre-exposure and post-exposure prophylaxis. The company's expertise in vaccine development and production has positioned it as a key player in the market.
- **GlaxoSmithKline plc**: GlaxoSmithKline plc is another prominent player in the rabies prophylaxis market, with a portfolio of vaccines and immunoglobulins for rabies prevention. The company's commitment to research and innovation drives its presence in the market.
- **Bayer AG**: Bayer AG is a significant player in the animal prophylaxis segment of the rabies market, offering vaccines for pets and livestock. The company's focus on animal health and welfare contributes to its market position.
- **Zoetis Inc.**: Zoetis Inc. specializes in animal health products, including vaccines for rabSanofi, GlaxoSmithKline plc, Bayer AG, and Zoetis Inc. are among the key players in the competitive rabies prophylaxis market. These companies have established themselves with a strong presence and offerings in both the human and animal segments of the market. Sanofi's expertise in vaccine development and production has enabled it to provide a comprehensive range of rabies vaccines for both pre-exposure and post-exposure prophylaxis. This positions the company as a leading player in the market, recognized for its commitment to public health and disease prevention. GlaxoSmithKline plc, on the other hand, has a portfolio of vaccines and immunoglobulins dedicated to rabies prevention, showcasing its emphasis on research and innovation to meet the evolving needs of the market.
Bayer AG, a significant player in the animal prophylaxis segment, offers vaccines tailored for pets and livestock to control rabies transmission among animals. The company's focus on animal health and welfare aligns with the increasing demand for effective prophylactic measures in the veterinary sector. Additionally, Zoetis Inc., specializing in animal health products, including vaccines for rabies, contributes unique insights to the market. By addressing the specific needs of the animal population, Zoetis Inc. plays a crucial role in preventing the spread of rabies among domestic and wild animals, thus supporting public health initiatives aimed at controlling zoonotic diseases.
The segmentation of the rabies prophylaxis market into biological and non-biological products reflects the diverse range of preventive measures available. Biological products such as vaccines, including PCECV and RVA, cater to the immunization needs of both humans and animals after exposure to the rabies virus. On the other hand, non-biological products like immunoglobulins serve as an additional layer of protection, especially in high-risk situations. The distribution channels, comprising hospitals, retail pharmacies, and e-commerce platforms, play a crucial role in the accessibility and availability of rabies proph**Global Rabies Prophylaxis Market Analysis**
The global rabies prophylaxis market is witnessing significant growth due to the increasing awareness about rabies prevention, rising incidence of rabies cases, and the emphasis on vaccination programs for both humans and animals. The market segmentation based on type, distribution channel, and end-users provides a comprehensive understanding of the market dynamics and trends.
**Segments**
- **Type**: The division of the market into biological and non-biological products caters to the diverse preventive measures available in rabies prophylaxis. Biological products, such as vaccines like PCECV and RVA, play a crucial role in immunizing individuals post-exposure to the rabies virus. Non-biological products, including immunoglobulins, offer an additional layer of protection, especially in high-risk situations.
- **Distribution Channel**: The segmentation based on distribution channels highlights the accessibility and availability of rabies prophylaxis products to consumers. Hospitals remain a primary source for rabies prophylaxis due to the administration of vaccines and immunoglobulins by healthcare professionals. Retail pharmacies and e-commerce platforms are emerging as convenient channels for consumers to access these products easily.
- **End-User**: The division based on end-users includes both humans and animals. Human prophylaxis involves the administration of vaccines and immunoglobulins post-exposure to the rabies virus to prevent the onset of the disease. Animal prophylaxis focuses on vaccination programs to control rabies transmission in domestic and
Highlights of TOC:
Chapter 1: Market overview
Chapter 2: Global Rabies Prophylaxis Market
Chapter 3: Regional analysis of the Global Rabies Prophylaxis Market industry
Chapter 4: Rabies Prophylaxis Market segmentation based on types and applications
Chapter 5: Revenue analysis based on types and applications
Chapter 6: Market share
Chapter 7: Competitive Landscape
Chapter 8: Drivers, Restraints, Challenges, and Opportunities
Chapter 9: Gross Margin and Price Analysis
Core Objective of Rabies Prophylaxis Market:
Every firm in the Rabies Prophylaxis Market has objectives but this market research report focus on the crucial objectives, so you can analysis about competition, future market, new products, and informative data that can raise your sales volume exponentially.
- Size of the Rabies Prophylaxis Market and growth rate factors.
- Important changes in the future Rabies Prophylaxis Market.
- Top worldwide competitors of the Market.
- Scope and product outlook of Rabies Prophylaxis Market.
- Developing regions with potential growth in the future.
- Tough Challenges and risk faced in Market.
- Global Rabies Prophylaxis top manufacturers profile and sales statistics.
Regional Analysis for Rabies Prophylaxis Market:
- APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, and Sri Lanka)
- Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Belgium, Denmark, Austria, Norway, Sweden, The Netherlands, Poland, Czech Republic, Slovakia, Hungary, and Romania)
- North America (U.S., Canada, and Mexico)
- South America (Brazil, Chile, Argentina, Rest of South America)
- MEA (Saudi Arabia, UAE, South Africa)
Browse Trending Reports:
Glucaric Acid Market
Coffee And Tea Processing Equipment Market
Nano Bioreactor Market
Shock Sensor Market
Metal Injection Molding Mim Market
Medical Billing Software Market
Feed Anticoccidials Market
Electric Motorcycles Market
Industrial Denox Systems Market
Seed Treatment Biofertilizers Market
Hemostasis Diagnostics Market
Poultry Feed Yeast Market
Functional Printing Market
Coagulation Reagents Market
Dandy Walker Treatment Market
Influenza Diagnostics Market
Pediatric Congenital Athymia Treatment Market
Grain Silos And Storage System Market
Heat Shrink Tubing Market
Structural Insulated Panel Market
Micro Flute Paper Market
Mens Grooming Products Market
Near Infrared Nir Portable Spectrometer Market
Mortuary Equipment Market
Medical Waste Disposal Services Market
About Data Bridge Market Research:
Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Contact Us:
Data Bridge Market Research
US: +1 614 591 3140
UK: +44 845 154 9652
APAC : +653 1251 975
